The Journal of Urology
Volume 183, Issue 3 , Pages 963-969 , March 2010

Increasing Hospital Admission Rates for Urological Complications After Transrectal Ultrasound Guided Prostate Biopsy

  • Robert K. Nam

      Affiliations

    • Division of Urology, Sunnybrook Research Institute, Toronto, Ontario, Canada
    • Department of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationCorrespondence: Division of Urology, Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Room MG-406, Toronto, Ontario, Canada M4N 3M5 (telephone: 416-480-5075; FAX: 416-480-6934)
    • Nothing to disclose.
    • ,
  • Refik Saskin

      Affiliations

    • Institute of Clinical Evaluative Sciences, University Health Network, Toronto, Ontario, Canada
    • Nothing to disclose.
    • ,
  • Yuna Lee

      Affiliations

    • Division of General Internal Medicine, St. Michael's Hospital, Toronto, Ontario, Canada
    • Nothing to disclose.
    • ,
  • Ying Liu

      Affiliations

    • Institute of Clinical Evaluative Sciences, University Health Network, Toronto, Ontario, Canada
    • Nothing to disclose.
    • ,
  • Calvin Law

      Affiliations

    • Division of General Surgery, Sunnybrook Research Institute, Toronto, Ontario, Canada
    • Department of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
    • Nothing to disclose.
    • ,
  • Laurence H. Klotz

      Affiliations

    • Division of Urology, Sunnybrook Research Institute, Toronto, Ontario, Canada
    • Financial interest and/or other relationship with Abbott, AstraZeneca, Aventis, Merck and GSK.
    • ,
  • D. Andrew Loblaw

      Affiliations

    • Department of Radiation Oncology, Sunnybrook Research Institute, Toronto, Ontario, Canada
    • Nothing to disclose.
    • ,
  • John Trachtenberg

      Affiliations

    • Division of Urology, University Health Network, Toronto, Ontario, Canada
    • Nothing to disclose.
    • ,
  • Aleksandra Stanimirovic

      Affiliations

    • Division of Urology, Sunnybrook Research Institute, Toronto, Ontario, Canada
    • Nothing to disclose.
    • ,
  • Andrew E. Simor

      Affiliations

    • Department of Microbiology and Division of Infectious Diseases, Sunnybrook Research Institute, Toronto, Ontario, Canada
    • Nothing to disclose.
    • ,
  • Arun Seth

      Affiliations

    • Division of Molecular and Cellular Biology, Sunnybrook Research Institute, Toronto, Ontario, Canada
    • Nothing to disclose.
    • ,
  • David R. Urbach

      Affiliations

    • Division of General Surgery, University Health Network, Toronto, Ontario, Canada
    • Department of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
    • Nothing to disclose.
    • ,
  • Steven A. Narod

      Affiliations

    • Department of Public Health Sciences, University of Toronto, Toronto, Ontario, Canada
    • Nothing to disclose.

Received 15 July 2009

References 

  1. Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol. 1989;142:66
  2. Terris MK. Ultrasonography and biopsy of the prostate. In:  Walsh PC,  Retik AB,  Vaughan ED, et al. editor. 8th ed.. Campbell's Urology. vol. 4:Philadelphia: Saunders; 2002;p. 3038–3054
  3. Kapoor DA, Klimberg IW, Malek GH, et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology. 1998;52:552
  4. Aron M, Rajeev TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int. 2000;85:682
  5. Ghani KR, Dundas D, Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol. BJU Int. 2004;94:1014
  6. Sieber PR, Rommel FM, Theodoran CG, et al. Contemporary prostate biopsy complication rates in community-based urology practice. Urology. 2007;70:498
  7. Feliciano J, Teper E, Ferrandino M, et al. The incidence of fluoroquinolone resistant infections after prostate biopsy–are fluoroquinolones still effective prophylaxis?. J Urol. 2008;179:952
  8. Raaijmakers R, Kirkels WJ, Roobol MJ, et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology. 2002;60:826
  9. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613
  10. Lee G, Attar K, Laniado M, et al. Trans-rectal ultrasound guided biopsy of the prostate: nationwide diversity in practice and training in the United Kingdom. Int Urol Nephrol. 2007;39:185
  11. Jeon SS, Woo SH, Hyun JH, et al. Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. Urology. 2003;62:461
  12. Laupland KB, Ross T, Pitout JD, et al. Community-onset urinary tract infections: a population-based assessment. Infection. 2007;35:150
  13. de la Taille A, Antiphon P, Salomon L, et al. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology. 2003;61:1181
  14. Presti JC, Chang JJ, Bhargava V, et al. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol. 2000;163:163
  15. Roehrborn CG, Nuckolls JG, Wei JT, et al. The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics. BJU Int. 2007;100:813
  16. Giannarini G, Mogorovich A, Valent F, et al. Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial. Urology. 2007;70:501
  17. Begg CB, Riedel ER, Bach PB, et al. Variations in morbidity after radical prostatectomy. N Engl J Med. 2002;346:1138

 Study received research ethics board approval.

 Supported by National Cancer Institute Grant 010294 and the Canadian Institute of Health Research.

 Supplementary material for this article can be obtained at www.prostaterisk.ca.

 See Editorial on page 852.

 Editor's Note: This article is the fourth of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 1262 and 1263.

PII: S0022-5347(09)02932-2

doi: 10.1016/j.juro.2009.11.043

The Journal of Urology
Volume 183, Issue 3 , Pages 963-969 , March 2010

Article Tools

* Image Usage & Resolution